Edwards appoints new ceo and cfo to drive future growth
The Board of Directors has announced changes to executive management
Nigel Hunton, who has been chief executive for the past four years, will take over the role of chairman with immediate effect.
Matthew Taylor will become ceo and David Smith, cfo. Taylor and Smith, who previously worked together in senior management positions at Jaguar Land Rover (JLR), and Ford Europe, bring extensive international leadership experience to Edwards.
Taylor was most recently the group chief executive officer of JC Bamford Excavators, the market leading global construction equipment company, where he worked from 2006. Previously he spent over 20 years with Ford, culminating in his role as md of Land Rover.
Smith brings 25 years blue-chip international experience with Ford and JLR, the last 13 years in cfo or ceo positions. Following his time as cfo of JLR, he went on to become ceo of the business from 2008-2010, during which time he steered it successfully through the complex ownership transition from Ford to Tata. Prior to JLR, David was finance and business strategy director, Premier Auto Group and Ford Europe.
Edwards employs around 3000 people worldwide in the design, manufacture and support of high technology vacuum and exhaust management equipment, as well as providing a wide range of other pumping technologies and related products. As chairman, Nigel Hunton will continue his active involvement in the business, advising the Board of Directors and the new ceo and focusing in particular on key customers, new product and market opportunities.
The Board is also announcing that, as part of these changes, the current finance director, Chris Bradley, has decided to leave the company. The Board would like to thank Chris for his very strong contribution to the business over the past 8 years.
Nigel Hunton, commented, “I am pleased to welcome Matthew and David to Edwards and look forward to working with them as we continue to deliver success for the company. 2010 is shaping up to be the best year in our 91 year history built on our restructuring actions, new products and new emerging markets. Edwards now has a broader and stronger management team to deliver successfully high technology solutions for our customers and capitalise on opportunities in all our markets”
You may also like
Sustainability
BioDuro sites recognised with EcoVadis Gold and Silver sustainability certifications
Three of the CDMO's Chinese sites have been recognised for outstanding sustainability performance, highlighting BioDuro’s commitment to sustainability and its ongoing efforts to embed environmental and social responsibility into its business operations
Manufacturing
IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility
Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
Manufacturing
Cellistic launches three new iPSC-based GMP platforms to advance immuno-oncology and regenerative therapies
The three new iPSC-derived GMP manufacturing platforms, Echo-T, Echo-Cardio and Echo-Endothelial, expand the company’s Echo portfolio and are designed to improve scalability and manufacturability across immuno-oncology and regenerative medicine programmes
Manufacturing
The role of vacuum drying in battery manufacturing: From precursors to cell assembly
Lithium-ion battery manufacturers place enormous emphasis on material purity, structural integrity, and process control. Vacuum drying, used at both the precursor and electrode stages, has become an important step in achieving these performance and safety targets. Let’s explore where and how vacuum drying fits into modern battery production and how Powder Systems Ltd’s tray drying technology supports this growing need
Manufacturing
Jubilant Biosys doubles chemistry capacity with new Noida facility in India
The company has announced the opening of a new discovery and preclinical facility in Noida, combining discovery and early-phase scale-up capabilities with R&D labs and two pilot plants to meet growing demand for FFS contracts
Manufacturing
Aragen launches CHOMax platform to accelerate DNA-to-IND biologics development
The platform is designed to deliver IND-enabling clinical supply in around 10 months for suitable IgG antibodies, combining CHO cell line development, process and analytical development and GMP drug substance support to reduce timelines